Company: ALGN
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0001097149-25-000021
Chunk: 8

Company: ALIGN TECHNOLOGY INC
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 8
---
 stockholders. The proponent’s proposal is inconsistent with market practice and introduces unnecessary risks of disruption and inappropriate use of corporate assets from a small number of stockholders. Our strong corporate governance practices and demonstrated responsiveness to stockholders already provide stockholders with multiple channels to raise their concerns with our Board and management. |     | Page                 
 124                  |     | AGAINST              |

<div align='center'>2</div>

| Our Business |

Align is a global medical device company primarily engaged in the design, manufacture and marketing of Invisalign ® clear aligners for the treatment of malocclusions, or the misalignment of teeth, by orthodontists and general dental practitioners (“GPs”), Vivera™ retainers for retention, iTero™ intraoral scanners and services for dentistry, and exocad™ computer-aided design and computer-aided manufacturing (“CAD/CAM”) software for dental laboratories and dental practitioners. Our vision and strategy are to revolutionize orthodontic and restorative dentistry through digital treatment planning and implementation using the Align™ Digital Platform, an integrated suite of proprietary technologies and services designed to deliver a seamless, end-to-end solution for patients, consumers, orthodontists, GPs and lab partners. We strive to achieve our vision and strategy through key objectives made possible with the proprietary technologies and services of the Align™ Digital Platform to establish: clear aligners as the principal solution for the treatment of malocclusions with the Invisalign System as the treatment solution of choice by orthodontists, GPs and patients globally, our iTero intraoral scanners as the preferred scanning technology for digital dental scans and our exocad CAD/CAM software as the dental restorative solution of choice for dental labs.

| 2024 Performance Highlights |

In 2024, we remained steadfast in our commitment to our doctor customers and their patients and further extended our leadership in digital orthodontics and restorative dentistry by focusing on and executing our strategic growth drivers:

| International Expansion                                                                                                                                                                            |     | GP Dentist Treatment                                                                                                                                                                                                                                                                                                                   |     | Patient Demand                                                                                                                                                                                                                                                                                   |     | Orthodontist Utilization                                                                                                                                                                                                                                                       |
| We continue increasing the presence of our operations and commercial organization globally, expanding our products and service offerings and trainings and educating more doctors in more markets. |     | We strive to enable GPs, who have the potential to treat the general patient population, to more easily identify potential cases they can treat with the Invisalign System, monitor patient progress or, if